The Current Ratio as of November 2024 (TTM) for Lipocine Inc. (LPCN) is 12.56

According to Lipocine Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.56. This represents a change of 2.08% compared to the average of 12.30 of the last 4 quarters.

Lipocine Inc. (LPCN) Historical Current Ratio (quarterly & annually)

How has LPCN Current Ratio performed in the past?

The mean historical Current Ratio of Lipocine Inc. over the last ten years is 10.45. The current 12.56 Current Ratio has changed 11.92% with respect to the historical average. Over the past ten years (40 quarters), LPCN's Current Ratio was at its highest in in the June 2015 quarter at 26.52. The Current Ratio was at its lowest in in the September 2019 quarter at 3.31.

Lipocine Inc. (LPCN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lipocine Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipocine Inc. (LPCN) Average Current Ratio

How has LPCN Current Ratio performed in the past?

The current Current Ratio of Lipocine Inc. (LPCN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lipocine Inc. (LPCN) Current Ratio vs. Peers

How is LPCN’s Current Ratio compared to its peers?

Lipocine Inc.’s Current Ratio is greater than Sigilon Therapeutics, Inc. (1.78), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Kiromic BioPharma, Inc. (0.35), greater than Unicycive Therapeutics, Inc. (3.37), greater than Checkpoint Therapeutics, Inc. (0.26), greater than Mustang Bio, Inc. (0.46), greater than Fortress Biotech, Inc. (1.37), greater than Kodiak Sciences Inc. (10.59), greater than Ardelyx, Inc. (4.03), less than Zura Bio Limited (12.57), greater than Hepion Pharmaceuticals, Inc. (5.62), less than AVROBIO, Inc. (26.17), greater than Verastem, Inc. (3.28), less than Reviva Pharmaceuticals Holdings, Inc. (0), greater than Eyenovia, Inc. (0.41), greater than Cognition Therapeutics, Inc. (0.43), greater than TransCode Therapeutics, Inc. (3.07), greater than null (1.25),

Build a custom stock screener for Lipocine Inc. (LPCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipocine Inc. (LPCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.